Lipo Lab

Lipo Lab is a Korean-origin commercial name used for more than one body- or face-contouring solution. The name does not identify one standardized formulation. Current brand material separates Lipo Lab PPC Solution, Lipo Lab V-Line, and Lemon Edge, while commercial listings attach different ingredient and package descriptions to the individual variants.

Quick reference

Field	Lipo Lab
Product-family scope	PPC Solution, V-Line, and Lemon Edge on the current MEDIHUB brand site
PPC Solution declared ingredients	Phosphatidylcholine (PPC) and sodium deoxycholate; some sales material also lists L-carnitine and sodium hyaluronate
PPC Solution presentation	Commonly listed as 10 mL × 10 vials
V-Line identity	A separate face-line product; its published ingredient descriptions differ from PPC Solution
Verified concentration	Not established from a current regulator-hosted label or public brand specification reviewed here
United States status	Lipo Lab fat-dissolving injections are not FDA approved
Company context	MEDIHUB claims the +Lipo Lab trademark and says it plans and manufactures the brand; it identifies Vel Korea as global distributor
Key limitation	Public commercial pages conflict or provide incomplete specifications; exact manufacturer and authorization holder require market-specific verification

The family structure and claimed company relationships come from the current Korean +Lipo Lab site (MEDIHUB +Lipo Lab 🔗). Ingredient and packaging descriptions are available on separate commercial sites but are not equivalent to a regulator-hosted label (Lipo Lab commercial product listing 🔗).

One name, multiple variants

The MEDIHUB brand site currently presents three products:

Variant	Brand-site positioning	What can be stated cautiously
Lipo Lab PPC Solution	Body-line PPC-based solution	Commercial listings associate it with PPC and sodium deoxycholate
Lipo Lab V-Line	Face-line product	Do not carry the PPC Solution formula over to V-Line
Lemon Edge	Skin-care line	Do not infer an injectable route from its placement beside the other variants

The brand site’s individual product pages currently say that detailed descriptions are being prepared. This makes variant name, package image, lot documentation, and exact source particularly important. Lipo Lab without a variant is not a sufficient formulation record.

Declared formulation and unresolved specification

A Lipo Lab sales site lists PPC Solution as 10 mL × 10 vials and declares phosphatidylcholine plus sodium deoxycholate as its main ingredients. A more detailed page on that site adds L-carnitine and sodium hyaluronate (Lipo Lab PPC listing 🔗). Because that site also publishes treatment and performance claims and sells the product directly, its contents should be treated as commercial declarations rather than an independently verified specification.

The reviewed sources do not establish:

• quantitative PPC and sodium-deoxycholate concentrations in a current official specification
• a regulator-hosted label or IFU
• whether all lots and generations use the same excipients
• a verified sterile-drug manufacturing site
• a national marketing authorization holder
• product-specific clinical evidence supporting the broad performance claims made by sellers

Do not use a reseller’s percentage, a photograph, or the statement PPC 1,000 mg as a substitute for a current finished-product specification.

Company roles and authenticity

MEDIHUB states that it owns the registered +Lipo Lab trademark and is engaged in brand planning, manufacturing, and export. The same site calls Vel Korea the global distributor and says that it guarantees products entering through the Vel Korea/MEDIHUB channel. It directs users to authenticate the package QR code (MEDIHUB +Lipo Lab 🔗).

These statements support narrow commercial relationships, but they do not fully resolve legal-manufacturer, physical-manufacturer, drug-authorization-holder, or local-distributor roles. Other sales pages refer to CSBIO Laboratories. Until those roles are supported by a current label, manufacturing record, or regulator entry, they should not be collapsed into the single word manufacturer.

United States status

The FDA specifically names Lipo Lab among fat-dissolving injections marketed and sold online that are not FDA approved. The agency notes that products in this category commonly contain PPC and sodium deoxycholate and reports adverse reactions including permanent scars, serious infections, skin deformities, cysts, and deep painful knots (FDA safety communication 🔗).

Not FDA approved describes US status. It should not be rewritten as illegal worldwide. A claim of sale, export, or professional use elsewhere also does not establish approval in that market.

Safety and evidence boundary

PPC/deoxycholate mixtures should not inherit Kybella’s product-specific evidence, concentration, indication, or label. Kybella’s FDA approval is for a defined deoxycholic-acid drug used for adult submental fat; it is not an ingredient-level approval for other formulations.

Commercial Lipo Lab sites publish injection depth, volumes, intervals, and outcome claims. Those instructions are not reproduced here because a verified current label and authorization context were not established. Product identity, authentic supply, sterile status, anatomy, professional qualification, and complication readiness remain separate questions.

Practitioner interpretation

When documenting Lipo Lab, capture the exact variant, generation or package design, declared ingredient panel, vial size and count, lot, expiry, QR result, supplier, and applicable national status. If the concentration, manufacturing role, or intended route cannot be verified, record the uncertainty rather than filling it from another product or seller.

Nearby reference pages

• Fat-Reduction Injectables separates marketed formulations from verified authorizations.
• Aqualyx is described by its brand owner as phosphatidylcholine-free and should not be treated as the same formulation class.
• Kabelline is marketed as a deoxycholic-acid product rather than a documented PPC/deoxycholate mixture.